Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events

PURPOSE: To describe serum vascular endothelial growth factor (sVEGF) in patients with neovascular age-related macular degeneration (nAMD) receiving anti-VEGF agents and associations between sVEGF and systemic serious adverse events (SSAEs). DESIGN: Exploratory analyses of a randomized controlled tr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ophthalmol Retina
Main Authors: Rogers, Chris A., Scott, Lauren J., Reeves, Barnaby C., Downes, Susan, Lotery, Andrew J., Dick, Andrew D., Chakravarthy, Usha
Format: Artigo
Sprog:Inglês
Udgivet: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6278944/
https://ncbi.nlm.nih.gov/pubmed/30555977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oret.2017.05.015
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker